Feedback / Questions
AGX-148 - AgonOx
PH-762 TME - Phio Pharma
https://www.prnewswire.com/news-releases/phio-pharmaceuticals-announces-initiation-of-collaborative-clinical-trial-with-ph-762-agonoxs-tumor-infiltrating-lymphocyte-program-agx148-and-providence-cancer-institute-301832848.html
May 24, 2023
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next